Bellevue Life Sciences Stock Total Debt
| BLACW Stock | 0.04 0.00 0.000002% |
Bellevue Life Sciences fundamentals help investors to digest information that contributes to Bellevue Life's financial success or failures. It also enables traders to predict the movement of Bellevue Stock. The fundamental analysis module provides a way to measure Bellevue Life's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Bellevue Life stock.
Bellevue | Total Debt |
Bellevue Life Sciences Company Total Debt Analysis
Bellevue Life's Total Debt refers to the amount of long term interest-bearing liabilities that a company carries on its balance sheet. That may include bonds sold to the public, notes written to banks or capital leases. Typically, debt can help a company magnify its earnings, but the burden of interest and principal payments will eventually prevent the firm from borrow excessively.
Current Bellevue Life Total Debt | 4.11 M |
Most of Bellevue Life's fundamental indicators, such as Total Debt, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Bellevue Life Sciences is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Bellevue Total Debt Driver Correlations
Understanding the fundamental principles of building solid financial models for Bellevue Life is extremely important. It helps to project a fair market value of Bellevue Stock properly, considering its historical fundamentals such as Total Debt. Since Bellevue Life's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Bellevue Life's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Bellevue Life's interrelated accounts and indicators.
Click cells to compare fundamentals
In most industries, total debt may also include the current portion of long-term debt. Since debt terms vary widely from one company to another, simply comparing outstanding debt obligations between different companies may not be adequate. It is usually meant to compare total debt amounts between companies that operate within the same sector.
CompetitionBellevue Net Debt
Net Debt |
|
Based on the latest financial disclosure, Bellevue Life Sciences has a Total Debt of 4.11 M. This is 99.99% lower than that of the Capital Markets sector and significantly higher than that of the Financials industry. The total debt for all United States stocks is 99.92% higher than that of the company.
Bellevue Total Debt Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Bellevue Life's direct or indirect competition against its Total Debt to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Bellevue Life could also be used in its relative valuation, which is a method of valuing Bellevue Life by comparing valuation metrics of similar companies.Bellevue Life is currently under evaluation in total debt category among its peers.
Bellevue Fundamentals
| Number Of Shares Shorted | 3.31 K | ||||
| EBITDA | (35.39 K) | ||||
| Net Income | 403.78 K | ||||
| Total Debt | 4.11 M | ||||
| Cash Flow From Operations | (818.77 K) | ||||
| Total Asset | 36.63 M | ||||
| Retained Earnings | (3.91 M) | ||||
| Working Capital | (2.02 M) | ||||
| Net Asset | 36.63 M |
About Bellevue Life Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Bellevue Life Sciences's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Bellevue Life using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Bellevue Life Sciences based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Bellevue Stock Analysis
When running Bellevue Life's price analysis, check to measure Bellevue Life's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bellevue Life is operating at the current time. Most of Bellevue Life's value examination focuses on studying past and present price action to predict the probability of Bellevue Life's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bellevue Life's price. Additionally, you may evaluate how the addition of Bellevue Life to your portfolios can decrease your overall portfolio volatility.